ID   RCC5
AC   CVCL_E055
SY   RCC-5
DR   Cosmic; 1352068
DR   Wikidata; Q54949467
RX   PubMed=12351398;
RX   PubMed=15941683;
CC   HLA typing: A*09,32; B*07,49; C*w07 (PubMed=12351398).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 9
//
RX   PubMed=15941683;
RA   Wittnebel, Sebastian
RA   Jalil, Abdelali
RA   Thiery, Jerome
RA   Da Rocha, Sylvie
RA   Viey, Emilie
RA   Escudier, Bernard J.
RA   Chouaib, Salem
RA   Caignard, Anne
RT   "The sensitivity of renal cell carcinoma cells to interferon alpha
RT   correlates with p53-induction and involves Bax.";
RL   Eur. Cytokine Netw. 16:123-127(2005).
//
RX   PubMed=12351398; DOI=10.1182/blood-2002-02-0643;
RA   Guerra, Nadia
RA   Michel, Frederique
RA   Gati, Asma
RA   Gaudin, Catherine
RA   Mishal, Zohar
RA   Escudier, Bernard J.
RA   Acuto, Oreste
RA   Chouaib, Salem
RA   Caignard, Anne
RT   "Engagement of the inhibitory receptor CD158a interrupts TCR
RT   signaling, preventing dynamic membrane reorganization in CTL/tumor
RT   cell interaction.";
RL   Blood 100:2874-2881(2002).
//